Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

Kim Jooyeon

Seoul, Republic of Korea

Title: Selective Retina therapy in Patients with Central Serous Chorioretinopathy

Biography

Biography: Kim Jooyeon

Abstract


Purpose:
We evaluated visual outcomes, changes of central macular thickness in patients with central serous chorioretinopathy after treatment with selective retina therapy.
Methods:
Seventeen eyes of sixteen patients who were diagnosed with central serous chorioretinopathy will incuded in the study. Location of laser was determined by fundus fluorescein angiography performed before laser treatment. OCT was conducted before laser treatment and 1 month after laser treatment to compare central macular thickness. Chart review were done including age, sex, best correct visual acuity, intraocular pressure, slit lamp examination, time of laser conducted after diagnosis, location of laser conducted, side effects.
Results:
Average best correct visual acuity at diagnosis and 1 month after laser treatment was 0.20(logMAR) and 0.12(logMAR) respectively, showing 0.08(logMAR) of best correct visual acuity improvement. Average central macular thickness decreased 176.92um from 213±46um at baseline to 36±20um at 1 month after selective retina therapy.
Conclusion:
 SRT of central serous chorioretinopathy patients showed favorable visual and structural outcomes without the risk of scotoma or other untreatable side effects.